Volume: 24 Issue: 2

1. Current status and prospect of perioperative therapy for locally advanced gastric cancer. Page:101—106
2. Progress in conversion therapy for stage IV gastric cancer. Page:107—111
3. Exploration and thoughts on perioperative treatment of advanced gastric cancer. Page:112—117
4. Implementation strategy of enhanced recovery after surgery in perioperative management of gastric cancer. Page:118—121
5. Prehabilitation for gastrointestinal cancer patients. Page:122—127
6. Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial. Page:128—137
7. Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer. Page:138—144
8. Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection. Page:145—152
9. Risk factors of postoperative complication after total gastrectomy in advanced gastric cancer patients receiving neoadjuvant chemotherapy. Page:153—159
10. Postoperative complications and their influence on the prognosis factors in gastric cancer patients receiving neoadjuvant treatment. Page:160—166
11. Safety and feasibility of laparoscopic double-flap technique in digestive tract reconstruction after proximal gastrectomy for esophagogastric junction tumors larger than 5 cm. Page:167—172
12. Application of 3D-CT simulation image in the description of gastric artery variation to guide laparoscopic total gastrectomy. Page:173—178
13. Risk factors of postoperative pulmonary infection of gastric cancer and perioperative intervention measures. Page:185—190